DOI: 10.1111/cea.70462 ISSN: 0954-7894
Efficacy of Dupilumab in Patients From China With Persistent Type 2 Asthma With and Without an Allergic Phenotype
Qingling Zhang, Zhenan Deng, Xiuhua Fu, Haohui Fang, Jie Lin, Jérôme Msihid, Yvonne Huang, Jason H. Kwah, Olivier Ledanois, Nanshan ZhongSummary
Asthma is underdiagnosed and undertreated in China, where treatment with dupilumab could be beneficial. In this industry‐funded post hoc exploratory analysis, dupilumab showed clinical efficacy in allergic and non‐allergic asthma.